Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases.
暂无分享,去创建一个
M. Gresser | R. Zamboni | C. Ramachandran | R Zamboni | G Huyer | J Kelly | J Moffat | Z Jia | M J Gresser | C Ramachandran | J. Kelly | G. Huyer | Z. Jia | J. Moffat
[1] Hong Sun,et al. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.
[2] J. L. Bailey,et al. Techniques in protein chemistry , 1989 .
[3] L. Cantley,et al. Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains , 1997, Science.
[4] J. Dixon,et al. A continuous spectrophotometric and fluorimetric assay for protein tyrosine phosphatase using phosphotyrosine-containing peptides. , 1993, Analytical biochemistry.
[5] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[6] J Barsoum,et al. Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Saha,et al. CD45 protein tyrosine phosphatase: Determination of minimal peptide length for substrate recognition and synthesis of some tyrosine-based electrophiles as potential active-site directed irreversible inhibitors , 1995 .
[8] Zhou Songyang,et al. Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.
[9] F. Jirik,et al. Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains. , 1994, The Journal of biological chemistry.
[10] Hong Sun,et al. The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. , 1994, Trends in biochemical sciences.
[11] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[12] A. Ullrich,et al. Both SH2 Domains Are Involved in Interaction of SHP-1 with the Epidermal Growth Factor Receptor but Cannot Confer Receptor-directed Activity to SHP-1/SHP-2 Chimera* , 1997, The Journal of Biological Chemistry.
[13] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[14] M. Gresser,et al. Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate* , 1997, The Journal of Biological Chemistry.
[15] D. Barford,et al. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. , 1995, Science.
[16] N. Tonks,et al. Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST , 1996, Molecular and cellular biology.
[17] M. Bernier,et al. A Peptide-based Protein-tyrosine Phosphatase Inhibitor Specifically Enhances Insulin Receptor Function in Intact Cells* , 1996, The Journal of Biological Chemistry.
[18] D. Solas,et al. An Efficient Synthesis of N-α-Fmoc-4-(Phosphonodifluoromethyl)-l- phenylalanine , 1996 .
[19] K. Sharp,et al. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.
[20] M. Bernier,et al. A Synthetic Peptide Derived from a COOH-terminal Domain of the Insulin Receptor Specifically Enhances Insulin Receptor Signaling* , 1996, The Journal of Biological Chemistry.
[21] B. Neel,et al. From Form to Function: Signaling by Protein Tyrosine Phosphatases , 1996, Cell.
[22] S. Shoelson,et al. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking , 1997, Molecular and cellular biology.
[23] A. Levitzki,et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.
[24] R. Aebersold,et al. Comparison of the specificity of bacterially expressed cytoplasmic protein-tyrosine phosphatases SHP and SH-PTP2 towards synthetic phosphopeptide substrates. , 1995, European journal of biochemistry.
[25] Charis Eng,et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.
[26] P. Roller,et al. Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. , 1994, Biochemical and biophysical research communications.
[27] T. Hunter,et al. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.
[28] L. Wennogle,et al. Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detection. , 1996, Biochemistry.
[29] J. Dixon,et al. Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates. , 1994, Biochemistry.
[30] J. Dixon,et al. Substrate specificity of the protein tyrosine phosphatases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Walsh,et al. Substrate specificities of catalytic fragments of protein tyrosine phosphatases (HPTPβ, LAR, and CD45) toward phosphotyrosylpeptide substrates and thiophosphotyrosylated peptides as inhibitors , 1993, Protein science : a publication of the Protein Society.
[32] B. Jena,et al. Acidic residues are involved in substrate recognition by two soluble protein tyrosine phosphatases, PTP-5 and rrbPTP-1. , 1993, Biochemistry.
[33] N. Tonks. Protein Tyrosine Phosphatases and the Control of Cellular Signaling Responses , 1996 .
[34] J. Bishop,et al. Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. , 1994, The Journal of pharmacology and experimental therapeutics.
[35] L. Wu,et al. Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases? , 1995, Biochemical and biophysical research communications.
[36] T Pawson,et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav , 1994, Molecular and cellular biology.